Fourfold increase in investigational new drugs applications in India: DCGI
Dr VG Somani said that the "Made in India" drugs will make a difference and hit the world in the coming years.
New Delhi: Claiming that India is on course to become a 'global hub for medicines', Dr VG Somani, Drug Controller General of India (DCGI), said that there has been a fourfold increase in applications of the investigational new drugs in the country.Speaking at the Indian Drug Manufacturers' Association (IDMA) Annual Conclave, Somani said, "We are getting the applications of the investigational...
New Delhi: Claiming that India is on course to become a 'global hub for medicines', Dr VG Somani, Drug Controller General of India (DCGI), said that there has been a fourfold increase in applications of the investigational new drugs in the country.
Read also: Union Health Minister says PLI scheme boosts production of over 35 products in India
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd